FDA Chief Proposes Rules Changes to Fight High Drug Prices

Gottlieb urges new regulations to ease generic drug entry to U.S. market

FDA Commissioner Gottlieb
FDA Commissioner Gottlieb
While this is good news, I find it hard to reconcile with the President’s budget proposal for FDA, which includes a reduction of appropriated funds by doubling user fees. We all know that medical products firms will increase costs to consumers to cover the increased user fees. In the end, the American consumer will pay for this.